PLAT and hematocrit: This increased tendency of East-Asian populations to show higher rates of HT in response to IV-tPA treatment was also reflected in two randomized control trials in Japan and China [8,10], which showed higher rates of severe HT in the regular versus reduced IV-tPA dosage.